Jingqin Luo

16.2k total citations · 2 hit papers
194 papers, 8.0k citations indexed

About

Jingqin Luo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jingqin Luo has authored 194 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 56 papers in Pulmonary and Respiratory Medicine and 55 papers in Molecular Biology. Recurrent topics in Jingqin Luo's work include Glioma Diagnosis and Treatment (24 papers), Breast Cancer Treatment Studies (19 papers) and Advanced Breast Cancer Therapies (18 papers). Jingqin Luo is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Breast Cancer Treatment Studies (19 papers) and Advanced Breast Cancer Therapies (18 papers). Jingqin Luo collaborates with scholars based in United States, Canada and United Kingdom. Jingqin Luo's co-authors include Brett L. Knolhoff, David G. DeNardo, Yu Zhu, Andrea Wang‐Gillam, Melissa A. Meyer, Timothy M. Nywening, David C. Linehan, S. Peter Goedegebuure, Brian L. West and Joshua B. Rubin and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Jingqin Luo

182 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models

2014 974 citations Yu Zhu, Brett L. Knolhoff et al. Cancer Research profile →
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression

2017 585 citations Yu Zhu, Brett L. Knolhoff et al. profile →

Peers

Countries citing papers authored by Jingqin Luo

Since Specialization

Citations

This map shows the geographic impact of Jingqin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingqin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingqin Luo more than expected).

Fields of papers citing papers by Jingqin Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingqin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingqin Luo. The network helps show where Jingqin Luo may publish in the future.

Co-authorship network of co-authors of Jingqin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jingqin Luo. A scholar is included among the top collaborators of Jingqin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingqin Luo. Jingqin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of anemia and iron supplementation among glioblastoma patients reveals sex-biased association between anemia and survival 2024 ·Scientific Reports ·(unknown), Becky Slagle‐Webb, Chachrit Khunsriraksakul, (unknown), Jingqin Luo, Vladimir Khristov, Nataliya Smith, Alireza Mansouri, Brad E. Zacharia, Sheldon L. Holder, Justin D. Lathia, Jill S. Barnholtz‐Sloan, James R. Connor	1
2	Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy 2024 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), (unknown), Jingqin Luo, Robyn S. Klein, Albert H. Kim, Amy B. Heimberger, Chad A. Mirkin, Alexander H. Stegh, Natalie Artzi	12
3	Associations of Vitamins and Related Cofactor Metabolites with Mammographic Breast Density in Premenopausal Women 2023 ·Journal of Nutrition ·(unknown), (unknown), (unknown), Chongliang Luo, Jingqin Luo, Adetunji T. Toriola	3
4	Characterization of cell-type specific circular RNAs associated with colorectal cancer metastasis 2023 ·NAR Cancer ·Sidi Zhao, Amy Ly, Jacqueline L. Mudd, Emily B. Rozycki, (unknown), Emily Coonrod, (unknown), Jingqin Luo, Ha X. Dang, Ryan C. Fields, Christopher A. Maher	3
5	TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma 2023 ·Science Advances ·Rui Sun, Rowland H. Han, (unknown), Saad M. Khan, G. Travis Tabor, Yun Chen, Jinchao Hou, Haowu Jiang, Kathleen M. Schoch, Diane D. Mao, Ryan T. Cleary, Alicia Yang, Qin Liu, Jingqin Luo, Allegra A. Petti, Timothy M. Miller, Jason D. Ulrich, David M. Holtzman, Albert H. Kim	62
6	Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting 2022 ·Science Translational Medicine ·(unknown), Kiran Mahajan, Arun Renganathan, Cody Weimholt, Jingqin Luo, Vandna Kukshal, Joseph M. Jez, (unknown), Bo Zhang, Tiandao Li, Bin Fang, Yunting Luo, Nicholas J. Lawrence, Harshani R. Lawrence, Felix Y. Feng, Nupam P. Mahajan	19
7	TNK2/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability 2022 ·Autophagy ·Surbhi Chouhan, (unknown), Cody Weimholt, Jingqin Luo, Robert W. Sprung, (unknown), David M. Mueller, H. Shelton Earp, Nupam P. Mahajan	34
8	Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women 2018 ·Cancer Prevention Research ·Adetunji T. Toriola, Catherine M. Appleton, Xiaoyu Zong, Jingqin Luo, Katherine N. Weilbaecher, Rulla M. Tamimi, Graham A. Colditz	11
9	A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer 2015 ·Clinical Cancer Research ·X. Cynthia, Jingqin Luo, Michael Naughton, Foluso O. Ademuyiwa, Rama Suresh, Malachi Griffith, Obi L. Griffith, Zachary L. Skidmore, Nicholas C. Spies, Avinash Ramu, Lee Trani, Timothy Pluard, Gayathri Nagaraj, Shana Thomas, Zhanfang Guo, Jeremy Hoog, Jing Han, Elaine R. Mardis, (unknown), Matthew J. Ellis	77
10	CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models breakdown → 2014 ·Cancer Research ·Yu Zhu, Brett L. Knolhoff, Melissa A. Meyer, Timothy M. Nywening, Brian L. West, Jingqin Luo, Andrea Wang‐Gillam, S. Peter Goedegebuure, David C. Linehan, David G. DeNardo	974
11	Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models 2013 ·Molecular Cancer Therapeutics ·Siguang Xu, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, X. Cynthia	41
12	Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer 2012 ·Cancer Research ·Sangjun Lee, Sheila A. Stewart, Irıs D. Nagtegaal, Jingqin Luo, Yun Wu, Graham A. Colditz, Dan Medina, D. Craig Allred	119
13	Uterine Serous Carcinoma: Increased Familial Risk for Lynch-Associated Malignancies 2012 ·Cancer Prevention Research ·Summer Dewdney, Nora T. Kizer, Abegail A. Andaya, (unknown), Jingqin Luo, David G. Mutch, Amy P. Schmidt, Louise A. Brinton, Russell R. Broaddus, Nilsa C. Ramirez, Phyllis C. Huettner, D. Scott McMeekin, Kathleen M. Darcy, Shamshad Ali, Patricia L. Judson, Robert S. Mannel, Shashikant B. Lele, David M. O’Malley, Paul J. Goodfellow	17
14	Suppression of G-protein–Coupled Receptor Kinase 3 Expression Is a Feature of Classical GBM That Is Required for Maximal Growth 2011 ·Molecular Cancer Research ·B. Mark Woerner, Jingqin Luo, (unknown), Erin Jackson, Sonika Dahiya, Paul S. Mischel, Jeffrey Benovic, David Piwnica‐Worms, Joshua B. Rubin	33
15	Opposing Effects of Runx2 and Estradiol on Breast Cancer Cell Proliferation: In Vitro Identification of Reciprocally Regulated Gene Signature Related to Clinical Letrozole Responsiveness 2011 ·Clinical Cancer Research ·Nyam-Osor Chimge, Sanjeev K. Baniwal, Jingqin Luo, Simon G. Coetzee, Omar Khalid, Benjamin P. Berman, Debu Tripathy, Matthew J. Ellis, Baruch Frenkel	39
16	CXCR4 Activation Defines a New Subgroup of Sonic Hedgehog–Driven Medulloblastoma 2011 ·Cancer Research ·Rajarshi Sengupta, Adrian M. Dubuc, Stacey Ward, Lihua Yang, Paul A. Northcott, B. Mark Woerner, Kristen L. Kroll, Jingqin Luo, Michael D. Taylor, Robert J. Wechsler‐Reya, Joshua B. Rubin	48
17	Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome 2009 ·Clinical Cancer Research ·Andrew Berchuck, Edwin S. Iversen, Jingqin Luo, Jennifer Clarke, Hisani N. Horne, Douglas A. Levine, Jeff Boyd, Miguel A. Alonso, Angeles Alvarez Secord, Marcus Q. Bernardini, Jason C. Barnett, Todd Boren, Susan K. Murphy, Holly K. Dressman, Jeffrey R. Marks, Johnathan M. Lancaster	60
18	PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer 2009 ·Cancer Research ·Robert J. Crowder, Chanpheng Phommaly, Tao Yu, Jeremy Hoog, Jingqin Luo, Charles M. Perou, Joel S. Parker, Melinda A. Miller, David G. Huntsman, Lin Li, Jacqueline Snider, Sherri R. Davies, John A. Olson, Mark A. Watson, Anthony J. Saporita, Jason D. Weber, Matthew J. Ellis	174
19	Epigenetic Repression of microRNA-129-2 Leads to Overexpression of SOX4 Oncogene in Endometrial Cancer 2009 ·Cancer Research ·Yi-Wen Huang, Joseph C. Liu, Daniel E. Deatherage, Jingqin Luo, David G. Mutch, Paul J. Goodfellow, David S. Miller, Tim H-M. Huang	227
20	Measuring Overall Heterogeneity in Meta-Analyses: Application to CSF Biomarker Studies in Alzheimer’s Disease 2008 ·Journal of Modern Applied Statistical Methods ·Chengjie Xiong, Feng Gao, Yan Yan, Jingqin Luo, (unknown), Gang Shi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact